← FDA DRUG APPROVALS

FDA ANDA · ANDA077135

VALACYCLOVIR HYDROCHLORIDE

Sponsor: CIPLA

APPLICATION
ANDA077135
TYPE
ANDA
ORIGINAL APPROVAL
2010-05-24
LATEST ACTION
2023-03-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

VALACYCLOVIR HYDROCHLORIDEDiscontinued
VALACYCLOVIR HYDROCHLORIDE EQ 1GM BASE · TABLET · ORAL
VALACYCLOVIR HYDROCHLORIDEDiscontinued
VALACYCLOVIR HYDROCHLORIDE EQ 500MG BASE · TABLET · ORAL

Approval history

2023-03-22Labeling · Supplement 13 · standardAP
2023-03-22Labeling · Supplement 11 · standardAP
2015-10-28Labeling · Supplement 6 · standardAP
2010-05-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →